Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2027
Earnings, Q1 FY2027
Jul 30, 2026
Q1 revenue up 1.1% sequentially, BFSI leads growth, margins dip on large deal ramp-up.
2026
Investor presentation
May 26, 2026
AI-driven growth, robust financials, and ESG leadership marked FY26 performance.
Earnings, Q4 FY2026
Annual
Apr 24, 2026
Order book hit record high as AI-led wins and mega deal offset TMT sector headwinds.
Earnings, Q3 FY2026
Jan 23, 2026
Strong margins and cash flow offset modest revenue growth; BFSI outperformed, TMT lagged.
Earnings, Q2 FY2026
Oct 31, 2025
Steady Q2 growth driven by AI and core verticals, offset by TMT headwinds and strong cash position.
Earnings, Q1 FY2026
Jul 22, 2025
Q1 revenue up 3.3%, order book up 11.7% YoY, but margins face pressure from wage hikes.
2025
Earnings, Q4 FY2025
Annual
Apr 25, 2025
Solid Q4 growth, robust order book, and higher dividends amid macro uncertainty.
Earnings, Q3 FY2025
Jan 22, 2025
Q3 FY25 delivered strong growth, record order book, and margin gains, with a positive FY26 outlook.
Earnings, Q2 FY2025
Oct 22, 2024
Record order book, stable margins, and strong BFSI/healthcare growth offset TMT decline.